Six or eight cycles of CHOP plus rituximab for elderly patients with diffuse large B-cell lymphoma: Updated results of the RICOVER-60 trial

被引：0
|
作者：
Muneer, Sabeeha
Cunningham, Sonia
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2008年 / 8卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [21] No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study
    Sehn, Laurie H.
    Congiu, Angela Giovanna
    Culligan, Dominic J.
    Gironella, Mercedes
    Yoon, Dok Hyun
    Ogura, Michinori
    Rosta, Andras
    Zhu, Jun
    Launonen, Aino
    Nielsen, Tina
    Sellam, Gila
    Trneny, Marek
    Vitolo, Umberto
    Martelli, Maurizio
    BLOOD, 2018, 132
  • [22] VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly
    Fina, Mariapaola
    Tani, Monica
    Stefoni, Vittorio
    Musuraca, Gerardo
    Marchi, Enrica
    Pellegrini, Cinzia
    Alinari, Lapo
    Derenzini, Enrico
    Bacci, Francesco
    Pileri, Stefano
    Baccarani, Michele
    Zinzani, Pier Luigi
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2167 - 2171
  • [23] Results of CHOP chemotherapy for diffuse large B-cell lymphoma
    Hallack Neto, A. E.
    Pereira, J.
    Beitler, B.
    Chamone, D. A. F.
    Llacer, P. D.
    Dulley, F. L.
    Macedo, M. C. M. A.
    Chaoubah, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (10) : 1315 - 1322
  • [24] Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
    Ruan, Jia
    Martin, Peter
    Furman, Richard R.
    Lee, Shing M.
    Cheung, Ken
    Vose, Julie M.
    LaCasce, Ann
    Morrison, Julia
    Elstrom, Rebecca
    Ely, Scott
    Chadburn, Amy
    Cesarman, Ethel
    Coleman, Morton
    Leonard, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (06) : 690 - 697
  • [25] Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar, S
    Maghfoor, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1830 - 1831
  • [26] Bendamustine plus Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Vacirca, Jeffrey
    Tabbara, Imad
    Acs, Peter
    Shumaker, Grace
    BLOOD, 2010, 116 (21) : 1157 - 1157
  • [27] CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent.
    Linga, Vijay Gandhi
    Digumarti, Raghunadharao
    Maddi, Rahul Narayan
    Goteke, Vamshi Krishna Reddy
    Gundeti, Sadashivudu
    Thota, Narender Kumar
    Coca, Pragnya
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Response adapted assignment of the number of chemotherapy cycles for the treatment of patients with Diffuse Large B-cell Lymphoma (DLBCL) is not justified: Results of the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)
    Schubert, J.
    Ziepert, M.
    Lengfelder, E.
    Mohren, M.
    Peter, N.
    Reiser, M.
    Clemens, M.
    Nickenig, C.
    Bokemeyer, C.
    Ho, A. D.
    Eimermacher, H.
    Truemper, L.
    Hoffmann, M.
    Mertelsmann, R.
    Metzner, B.
    Mergenthaler, H. -G.
    Liersch, R.
    Duehrsen, U.
    Balleisen, L.
    Hartmann, F.
    Poeschel, V.
    Schmitz, N.
    Loeffler, M.
    Pfreundschuh, M.
    ONKOLOGIE, 2008, 31 : 120 - 120
  • [29] Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
    Decker, Michael
    Rothermundt, Christian
    Hollander, Georg
    Tichelli, Andre
    Rochlitz, Christoph
    LANCET ONCOLOGY, 2006, 7 (08): : 693 - 694
  • [30] Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
    Ennishi, D.
    Asai, H.
    Maeda, Y.
    Shinagawa, K.
    Ikeda, K.
    Yokoyama, M.
    Terui, Y.
    Takeuchi, K.
    Yoshino, T.
    Matsuo, K.
    Hatake, K.
    Tanimoto, M.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1217 - 1221
12345